No evidence of altered alveolar macrophage polarization, but reduced expression of TLR2, in bronchoalveolar lavage cells in sarcoidosis

Respiratory Research

Volumn 11, Issue , 2010, Pages

  Wikén, Maria ^a   Idali, Farah ^a,b   Al Hayja, Muntasir A ^a   Grunewald, Johan ^a   Eklund, Anders ^a   Wahlström, Jan ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b AVICENNA RESEARCH INSTITUTE   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CD86 ANTIGEN; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR7; CXCL11 CHEMOKINE; CXCL16 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INOSINATE DEHYDROGENASE; INTERLEUKIN 10; INTERLEUKIN 12P35; INTERLEUKIN 12P40; INTERLEUKIN 17; INTERLEUKIN 23P19; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TLR2 PROTEIN, HUMAN;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CELL POLARITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG ALVEOLUS MACROPHAGE; MALE; POLARIZATION; POLARIZATION AND DEPOLARIZATION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SARCOIDOSIS; AGED; BIOSYNTHESIS; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; IMMUNOLOGY; INNATE IMMUNITY; LUNG LAVAGE; METABOLISM; MIDDLE AGED;

ADULT; AGED; BRONCHOALVEOLAR LAVAGE FLUID; CELL POLARITY; CELLS, CULTURED; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, INNATE; MACROPHAGES, ALVEOLAR; MALE; MIDDLE AGED; SARCOIDOSIS, PULMONARY; TOLL-LIKE RECEPTOR 2;

EID: 79551595151     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-11-121     Document Type: Article

References (41)

1. Moller DR, Forman JD, Liu MC, Noble PW, Greenlee BM, Vyas P, Holden DA, Forrester JM, Lazarus A, Wysocka M, et al. Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis. J Immunol 1996, 156(12):4952-4960.
2. Idali F, Wiken M, Wahlstrom J, Mellstedt H, Eklund A, Rabbani H, Grunewald J. Reduced Th1 response in the lungs of HLA-DRB10301 patients with pulmonary sarcoidosis. Eur Respir J 2006, 27(3):451-459. 10.1183/09031936.06.00067105, 16507843.
3. Martinez FO, Sica A, Mantovani A, Locati M. Macrophage activation and polarization. Front Biosci 2008, 13:453-461. 10.2741/2692, 17981560.
4. Benoit M, Desnues B, Mege JL. Macrophage polarization in bacterial infections. J Immunol 2008, 181(6):3733-3739.
5. Katchar K, Eklund A, Grunewald J. Expression of Th1 markers by lung accumulated T cells in pulmonary sarcoidosis. J Intern Med 2003, 254(6):564-571. 10.1111/j.1365-2796.2003.01230.x, 14641797.
6. Agostini C, Cassatella M, Zambello R, Trentin L, Gasperini S, Perin A, Piazza F, Siviero M, Facco M, Dziejman M, et al. Involvement of the IP-10 chemokine in sarcoid granulomatous reactions. J Immunol 1998, 161(11):6413-6420.
7. Nishioka Y, Manabe K, Kishi J, Wang W, Inayama M, Azuma M, Sone S. CXCL9 and 11 in patients with pulmonary sarcoidosis: a role of alveolar macrophages. Clin Exp Immunol 2007, 149(2):317-326. 10.1111/j.1365-2249.2007.03423.x, 1941950, 17550373.
8. Agostini C, Cabrelle A, Calabrese F, Bortoli M, Scquizzato E, Carraro S, Miorin M, Beghe B, Trentin L, Zambello R, et al. Role for CXCR6 and its ligand CXCL16 in the pathogenesis of T-cell alveolitis in sarcoidosis. Am J Respir Crit Care Med 2005, 172(10):1290-1298. 10.1164/rccm.200501-142OC, 16100013.
9. Facco M, Baesso I, Miorin M, Bortoli M, Cabrelle A, Boscaro E, Gurrieri C, Trentin L, Zambello R, Calabrese F, et al. Expression and role of CCR6/CCL20 chemokine axis in pulmonary sarcoidosis. J Leukoc Biol 2007, 82(4):946-955. 10.1189/jlb.0307133, 17615381.
10. Louten J, Boniface K, de Waal Malefyt R. Development and function of TH17 cells in health and disease. J Allergy Clin Immunol 2009, 123(5):1004-1011. 10.1016/j.jaci.2009.04.003, 19410689.
11. Iwakura Y, Ishigame H. The IL-23/IL-17 axis in inflammation. J Clin Invest 2006, 116(5):1218-1222. 10.1172/JCI28508, 1451213, 16670765.
12. Saboor SA, Johnson NM, McFadden J. Detection of mycobacterial DNA in sarcoidosis and tuberculosis with polymerase chain reaction. Lancet 1992, 339(8800):1012-1015. 10.1016/0140-6736(92)90535-B, 1349051.
13. Abe C, Iwai K, Mikami R, Hosoda Y. Frequent isolation of Propionibacterium acnes from sarcoidosis lymph nodes. Zentralbl Bakteriol Mikrobiol Hyg [A] 1984, 256(4):541-547.
14. Song Z, Marzilli L, Greenlee BM, Chen ES, Silver RF, Askin FB, Teirstein AS, Zhang Y, Cotter RJ, Moller DR. Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis. J Exp Med 2005, 201(5):755-767. 10.1084/jem.20040429, 2212832, 15753209.
15. Drake WP, Dhason MS, Nadaf M, Shepherd BE, Vadivelu S, Hajizadeh R, Newman LS, Kalams SA. Cellular recognition of Mycobacterium tuberculosis ESAT-6 and KatG peptides in systemic sarcoidosis. Infect Immun 2007, 75(1):527-530. 10.1128/IAI.00732-06, 1828402, 17088357.
16. Chen ES, Wahlstrom J, Song Z, Willett MH, Wiken M, Yung RC, West EE, McDyer JF, Zhang Y, Eklund A, et al. T cell responses to mycobacterial catalase-peroxidase profile a pathogenic antigen in systemic sarcoidosis. J Immunol 2008, 181(12):8784-8796. 2700300, 19050300.
17. Berlin MF-HA, Olerup O, Eklund A, Grunewald J. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 1997, 156:1601-1605.
18. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999, 160(2):736-755.
19. Idali F, Wahlstrom J, Muller-Suur C, Eklund A, Grunewald J. Analysis of regulatory T cell associated forkhead box P3 expression in the lungs of patients with sarcoidosis. Clin Exp Immunol 2008, 152(1):127-137. 10.1111/j.1365-2249.2008.03609.x, 2384071, 18279440.
20. Idali F, Wahlstrom J, Dahlberg B, Khademi M, Olsson T, Eklund A, Grunewald J. Altered expression of T cell immunoglobulin-mucin (TIM) molecules in bronchoalveolar lavage CD4+ T cells in sarcoidosis. Respir Res 2009, 10:42. 10.1186/1465-9921-10-42, 2694180, 19480659.
21. Eklund A, Blaschke E. Relationship between changed alveolar-capillary permeability and angiotensin converting enzyme activity in serum in sarcoidosis. Thorax 1986, 41(8):629-634. 10.1136/thx.41.8.629, 460409, 3024350.
22. Wahlstrom J, Dahlen B, Ihre E, Wigzell H, Grunewald J, Eklund A. Selective CD8+ T cells accumulate in the lungs of patients with allergic asthma after allergen bronchoprovocation. Clin Exp Immunol 1998, 112(1):1-9. 10.1046/j.1365-2249.1998.00544.x, 1904944, 9566782.
23. Krause SW, Kreutz M, Andreesen R. Differential effects of cell adherence on LPS-stimulated cytokine production by human monocytes and macrophages. Immunobiology 1996, 196(5):522-534.
24. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162(1):156-159. 10.1016/0003-2697(87)90021-2, 2440339.
25. Perkin-Elmer Instruction manual. User Bulletin no. 2. Foster City, CA, USA. 1997, 1-36. Perkin-Elmer Applied Biosystems Inc.
26. Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 Cells. Annu Rev Immunol 2009, 27:485-517. 10.1146/annurev.immunol.021908.132710, 19132915.
27. Chaudhry A, Rudra D, Treuting P, Samstein RM, Liang Y, Kas A, Rudensky AY. CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner. Science 2009, 326(5955):986-991. 10.1126/science.1172702, 19797626.
28. Shigehara K, Shijubo N, Ohmichi M, Takahashi R, Kon S, Okamura H, Kurimoto M, Hiraga Y, Tatsuno T, Abe S, et al. IL-12 and IL-18 are increased and stimulate IFN-gamma production in sarcoid lungs. J Immunol 2001, 166(1):642-649.
29. Prasse A, Pechkovsky DV, Toews GB, Jungraithmayr W, Kollert F, Goldmann T, Vollmer E, Muller-Quernheim J, Zissel G. A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18. Am J Respir Crit Care Med 2006, 173(7):781-792. 10.1164/rccm.200509-1518OC, 16415274.
30. Mrazek F, Sekerova V, Drabek J, Kolek V, du Bois RM, Petrek M. Expression of the chemokine PARC mRNA in bronchoalveolar cells of patients with sarcoidosis. Immunol Lett 2002, 84(1):17-22. 10.1016/S0165-2478(02)00130-X, 12161279.
31. Prasse A, Pechkovsky DV, Toews GB, Schafer M, Eggeling S, Ludwig C, Germann M, Kollert F, Zissel G, Muller-Quernheim J. CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosis. Arthritis Rheum 2007, 56(5):1685-1693. 10.1002/art.22559, 17469163.
32. Kodera M, Hasegawa M, Komura K, Yanaba K, Takehara K, Sato S. Serum pulmonary and activation-regulated chemokine/CCL18 levels in patients with systemic sclerosis: a sensitive indicator of active pulmonary fibrosis. Arthritis Rheum 2005, 52(9):2889-2896. 10.1002/art.21257, 16142750.
33. Boot RG, Hollak CE, Verhoek M, Alberts C, Jonkers RE, Aerts JM. Plasma chitotriosidase and CCL18 as surrogate markers for granulomatous macrophages in sarcoidosis. Clin Chim Acta 2010, 411(1-2):31-36. 10.1016/j.cca.2009.09.034, 19808030.
34. Adema GJ, Hartgers F, Verstraten R, de Vries E, Marland G, Menon S, Foster J, Xu Y, Nooyen P, McClanahan T, et al. A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells. Nature 1997, 387(6634):713-717. 10.1038/42716, 9192897.
35. Wiken M, Grunewald J, Eklund A, Wahlstrom J. Higher Monocyte Expression of TLR2 and TLR4, and Enhanced Pro-inflammatory Synergy of TLR2 with NOD2 Stimulation in Sarcoidosis. J Clin Immunol 2008, 29(1):78-89. 10.1007/s10875-008-9225-0, 18773284.
36. Triantafilou M, Manukyan M, Mackie A, Morath S, Hartung T, Heine H, Triantafilou K. Lipoteichoic acid and toll-like receptor 2 internalization and targeting to the Golgi are lipid raft-dependent. J Biol Chem 2004, 279(39):40882-40889. 10.1074/jbc.M400466200, 15247273.
37. Maris NA, Dessing MC, de Vos AF, Bresser P, van der Zee JS, Jansen HM, Spek CA, van der Poll T. Toll-like receptor mRNA levels in alveolar macrophages after inhalation of endotoxin. Eur Respir J 2006, 28(3):622-626. 10.1183/09031936.06.00010806, 16946093.
38. Flo TH, Halaas O, Torp S, Ryan L, Lien E, Dybdahl B, Sundan A, Espevik T. Differential expression of Toll-like receptor 2 in human cells. J Leukoc Biol 2001, 69(3):474-481.
39. Afzali B, Mitchell P, Lechler RI, John S, Lombardi G. Translational mini-review series on Th17 cells: induction of interleukin-17 production by regulatory T cells. Clin Exp Immunol 159(2):120-130. 10.1111/j.1365-2249.2009.04038.x, 19912251.
40. Shaykhiev R, Krause A, Salit J, Strulovici-Barel Y, Harvey BG, O'Connor TP, Crystal RG. Smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of chronic obstructive pulmonary disease. J Immunol 2009, 183(4):2867-2883. 10.4049/jimmunol.0900473, 2873685, 19635926.
41. Woodruff PG, Koth LL, Yang YH, Rodriguez MW, Favoreto S, Dolganov GM, Paquet AC, Erle DJ. A distinctive alveolar macrophage activation state induced by cigarette smoking. Am J Respir Crit Care Med 2005, 172(11):1383-1392. 10.1164/rccm.200505-686OC, 2718436, 16166618.